| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 80,551 | 81,873 | 60,190 | 50,020 | | Cost of Revenue | 10,217 | 14,120 | 3,929 | 2,110 | | | Gross Profit | 70,334 | 67,753 | 56,261 | 47,910 | | | Operating Expenses | | Research Development | 11,007 | 12,353 | 19,798 | 21,197 | | Selling General and Administrative | 20,150 | 23,726 | 24,264 | 22,357 | | Non Recurring |
-
|
-
| 65,099 | 2,265 | | Others | 6,751 | 7,424 | 7,257 | 5,505 | | | | Total Operating Expenses |
-
|
-
| 116,418 | 51,324 | | | | Operating Income or Loss | 32,426 | 24,250 | (60,157) | (3,414) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 65 | 106 | 9,223 | 828 | | Earnings Before Interest And Taxes | 32,491 | 24,356 | (50,934) | (2,586) | | Interest Expense | 2,817 | 2,677 | 3,309 | 1,532 | | Income Before Tax | 29,674 | 21,679 | (54,243) | (4,118) | | Income Tax Expense | 9,602 | 5,627 | 4,972 | (3,141) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 20,072 | 16,052 | (59,215) | (977) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 20,072 | 16,052 | (59,215) | (977) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $20,072 | $16,052 | ($59,215) | ($977) |
|
0.02% Nasdaq 0.00%
Income Statement
